Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an important medication for the treatment of type 2 diabetes mellitus. Patients pay close attention to issues such as the legitimacy of its purchase channels, safety of use, and identification of product authenticity.
Where to Purchase Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Overseas Purchase
Patients may choose to consult and purchase the tablets at hospital pharmacies or licensed drugstores in countries/regions where Sitagliptin/Metformin Hydrochloride Extended-Release Tablets have been marketed.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
Purchase via Medical Service Institutions
Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
These institutions can usually provide legal import channels, as well as professional consultation and guidance services.
Precautions for Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Strictly Follow the Doctor’s Instructions
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets are prescription-only drugs and must be used under the professional evaluation and guidance of an endocrinologist.
The attending physician will determine the appropriate initial dose based on factors such as whether the patient is already receiving metformin treatment.
Indication Scope
Combined with diet and exercise, Sitagliptin/Metformin Hydrochloride Extended-Release Tablets are indicated to improve glycemic control in adult patients with type 2 diabetes mellitus.
It should be noted that this drug is not indicated for the treatment of type 1 diabetes mellitus, nor has it been studied in patients with a history of pancreatitis.
Identification of Authentic Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Appearance Feature Identification
The extended-release tablets containing 100 mg sitagliptin and 1000 mg metformin hydrochloride are blue, biconvex oval film-coated tablets, engraved with "81" on one side.
The extended-release tablets containing 50 mg sitagliptin and 500 mg metformin hydrochloride are light blue, biconvex oval film-coated tablets, engraved with "78" on one side.
The extended-release tablets containing 50 mg sitagliptin and 1000 mg metformin hydrochloride are light green, biconvex oval film-coated tablets, engraved with "80" on one side.
Anti-Counterfeiting Feature Verification
Packaging integrity check: The packaging of genuine drugs should be intact, with tight seals and no signs of damage or repackaging.
Drug information verification: Check whether the drug approval number, production batch number, validity period and other information on the package box are clear and complete.
Drug source traceability: The authenticity of the drug approval number can be verified through the official website of the national drug regulatory authority to ensure the legality of the drug source.
Batch number and validity period matching: Carefully check whether the batch number and validity period on the inner and outer packaging of the drug are consistent; any discrepancy may indicate a counterfeit product.
